Edwards Lifesciences (Germany) Performance
| EWL Stock | EUR 70.08 0.26 0.37% |
On a scale of 0 to 100, Edwards Lifesciences holds a performance score of 11. The firm shows a Beta (market volatility) of 0.0559, which means not very significant fluctuations relative to the market. As returns on the market increase, Edwards Lifesciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Edwards Lifesciences is expected to be smaller as well. Please check Edwards Lifesciences' treynor ratio, downside variance, kurtosis, as well as the relationship between the value at risk and expected short fall , to make a quick decision on whether Edwards Lifesciences' price patterns will revert.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Edwards Lifesciences reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 867.4 M | |
| Free Cash Flow | 953.4 M |
Edwards |
Edwards Lifesciences Relative Risk vs. Return Landscape
If you would invest 6,026 in Edwards Lifesciences on September 23, 2024 and sell it today you would earn a total of 982.00 from holding Edwards Lifesciences or generate 16.3% return on investment over 90 days. Edwards Lifesciences is currently producing 0.2423% returns and takes up 1.6508% volatility of returns over 90 trading days. Put another way, 14% of traded stocks are less volatile than Edwards, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Edwards Lifesciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Edwards Lifesciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Edwards Lifesciences, and traders can use it to determine the average amount a Edwards Lifesciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1468
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | EWL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.65 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Edwards Lifesciences is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Edwards Lifesciences by adding it to a well-diversified portfolio.
Edwards Lifesciences Fundamentals Growth
Edwards Stock prices reflect investors' perceptions of the future prospects and financial health of Edwards Lifesciences, and Edwards Lifesciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Edwards Stock performance.
| Return On Equity | 0.26 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.28 % | |||
| Operating Margin | 0.33 % | |||
| Current Valuation | 43.48 B | |||
| Shares Outstanding | 608.31 M | |||
| Price To Earning | 45.19 X | |||
| Price To Book | 7.49 X | |||
| Price To Sales | 8.30 X | |||
| Revenue | 5.38 B | |||
| EBITDA | 1.93 B | |||
| Cash And Equivalents | 963 M | |||
| Cash Per Share | 4.62 X | |||
| Total Debt | 596.3 M | |||
| Debt To Equity | 19.30 % | |||
| Book Value Per Share | 9.55 X | |||
| Cash Flow From Operations | 1.22 B | |||
| Earnings Per Share | 2.35 X | |||
| Total Asset | 8.29 B | |||
About Edwards Lifesciences Performance
By analyzing Edwards Lifesciences' fundamental ratios, stakeholders can gain valuable insights into Edwards Lifesciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Edwards Lifesciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Edwards Lifesciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12800 people.Things to note about Edwards Lifesciences performance evaluation
Checking the ongoing alerts about Edwards Lifesciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Edwards Lifesciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 87.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Edwards Lifesciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Edwards Lifesciences' stock is overvalued or undervalued compared to its peers.
- Examining Edwards Lifesciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Edwards Lifesciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Edwards Lifesciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Edwards Lifesciences' stock. These opinions can provide insight into Edwards Lifesciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |